SCHEMBL7300199

SCHEMBL7300199

CC1(C)CC(O)c2ncccc2O1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.42
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
TLR3 O15455 1/20 0.35
TRPV1 Q8NER1 1/20 0.32
P2RX7 Q99572 2/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
OPRL1 P41146 1/20 0.31
KCNH2 Q12809 1/20 0.31
PDE4D Q08499 2/20 0.31
ADRA1D P25100 1/20 0.30
ADRA1A P35348 1/20 0.30
ADRA1B P35368 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12162418 0.76 EPHX2 (0.51) EPHX2KMT2AP2RX7OPRL1
SCHEMBL1115209 0.76 EPHX2 (0.51) EPHX2KMT2AP2RX7OPRL1
SCHEMBL7300358 0.74 CNR1 (0.41) SMN1; SMN2TLR3P2RX7CNR1CNR2
SCHEMBL31253977 0.73 MEN1 (0.43) MEN1KMT2ATLR3TRPV1CNR1
SCHEMBL13573386 0.73 MEN1 (0.43) MEN1KMT2ATLR3TRPV1CNR1
SCHEMBL3580439 0.73 MEN1 (0.43) MEN1KMT2ATLR3TRPV1CNR1
SCHEMBL15021653 0.73 MEN1 (0.43) MEN1KMT2ATLR3TRPV1CNR1
SCHEMBL9527672 0.71 SMN1; SMN2 (0.36) MEN1KMT2ASMN1; SMN2TRPV1OPRL1
SCHEMBL19852041 0.70 P2RX7 (0.39) MEN1KMT2ASMN1; SMN2P2RX7
SCHEMBL4237120 0.69 MEN1 (0.46) MEN1KMT2ATLR3TRPV1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4355748-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2024-04-24 EP disclosed
CN-117881681-A Substituted pyrrolo [2,3-d ] pyrimidines, their preparation and their therapeutic use 赛诺菲 2024-04-12 CN disclosed
WO-2022263472-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-12-22 WO disclosed
WO-2022263472-A1 SUBSTITUTED PYRROLO[2,3-D]PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-12-22 WO disclosed
EP-4105218-A1 SUBSTITUTED PYRROLO[2,3-D] PYRIMIDINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI (FR) 2022-12-21 EP disclosed
EP-0308792-B1 AZACHROMANE DERIVATIVES MERCK PATENT GmbH (DE) 1993-07-28 EP disclosed
US-4931454-A Azachroman derivatives with effects on the cardiovascular system MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1990-06-05 US disclosed
EP-0308792-A2 Azachromane derivatives MERCK PATENT GmbH (DE) 1989-03-29 EP disclosed